Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register.
Fine-tuning the central nervous system: microglial modelling of cells and synapses.
Axonal Loss in a Rat Model of Optic Neuritis Is Closely Correlated with Visual Evoked Potential Amplitudes Using Electroencephalogram-based Scaling.
A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis (ASCEND in SPMS)
B cells and antibodies in multiple sclerosis pathogenesis and therapy.
[Lyme disease in patients with multiple sclerosis: clinical, diagnostic and therapeutic features.]
Personalized Medicine in Neurodegenerative Diseases: How Far Away?
Neuromyelitis optica: clinical manifestations and neuroimaging features.
[Unified assessment of adverse events of multiple sclerosis disease modifying drugs.]
FDA Approves First Drug for Lou Gehrig's Disease
Assessing upper limb function in multiple sclerosis.
The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients.
Multiple sclerosis: Cognitive status declines on warmer days in patients with multiple sclerosis.
Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis.
PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation.
Rationale and design of a clinical trial investigating resistance training as an aid to smoking cessation in persons with multiple sclerosis.
TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis.
Microglia: Architects of the Developing Nervous System.
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients.
Dilantin (phenytoin) Supplemental Approval Letter
Quantitative Evaluation of BAFF, HMGB1, TLR 4 AND TLR 7 Expression in Patients with Relapsing Remitting Multiple Sclerosis.
Regulation of encephalitogenicity of neuroantigen-primed T cells by nitric oxide: Implications for multiple sclerosis.
Comorbid Multiple Sclerosis and TDP-43 Proteinopathy in a Gulf War Sea Captain.
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection.
Pages
« first
‹ previous
…
158
159
160
161
162
163
164
165
166
…
next ›
last »